A novel oncolytic virus induces a regional cytokine storm and safely eliminates malignant ascites of colon cancer. (5th May 2022)
- Record Type:
- Journal Article
- Title:
- A novel oncolytic virus induces a regional cytokine storm and safely eliminates malignant ascites of colon cancer. (5th May 2022)
- Main Title:
- A novel oncolytic virus induces a regional cytokine storm and safely eliminates malignant ascites of colon cancer
- Authors:
- Dong, Shuang
Liu, Binlei
Hu, Sheng
Guo, Fang
Zhong, Yi
Cai, Qian
Zhang, Siqi
Qian, Yu
Wang, Jun
Zhou, Fuxiang - Abstract:
- Abstract: Background: Given malignant ascites with a terrible prognosis and a unique immune microenvironment, our purpose is to evaluate whether oncolytic herpes simplex virus type 2(OH2) is able to safely eliminate ascites of colon cancer and through which specific mechanism it exerts antitumor immunity. Methods: We established an ascites mice model through intraperitoneal injection of CT26 cells and obtained an appropriate dose range for in vivo tests. Efficacy and safety of OH2 were detected by weight of ascites, blood routine analysis, histopathological examination, and the survival time of mice. The specific mechanism underlying antitumor immunity was analyzed by cytometric bead array, flow cytometry, and single‐cell RNA sequencing. Furthermore, anti‐interleukin (IL)‐6R antibody tocilizumab was synchronously or sequentially delivered with OH2 to explore the role of the regional cytokine storm, mainly IL‐6 hypersecretion. Results: OH2 was able to eliminate ascites and significantly prolong the survival of mice‐bearing CT26 tumor cells by intraperitoneal injection, without obvious systemic damage to the main organs even though a regional cytokine storm. Hypersecretion of pro‐inflammatory cytokines, mainly IL‐6, and increased infiltration of CD4+ and CD8+ T cells were observed in ascites mice treated by OH2, compared with those treated by 5‐fluorouracil or nonresponders. Furthermore, the initial‐stage blocking of the IL‐6 pathway was able to considerably suppress antitumorAbstract: Background: Given malignant ascites with a terrible prognosis and a unique immune microenvironment, our purpose is to evaluate whether oncolytic herpes simplex virus type 2(OH2) is able to safely eliminate ascites of colon cancer and through which specific mechanism it exerts antitumor immunity. Methods: We established an ascites mice model through intraperitoneal injection of CT26 cells and obtained an appropriate dose range for in vivo tests. Efficacy and safety of OH2 were detected by weight of ascites, blood routine analysis, histopathological examination, and the survival time of mice. The specific mechanism underlying antitumor immunity was analyzed by cytometric bead array, flow cytometry, and single‐cell RNA sequencing. Furthermore, anti‐interleukin (IL)‐6R antibody tocilizumab was synchronously or sequentially delivered with OH2 to explore the role of the regional cytokine storm, mainly IL‐6 hypersecretion. Results: OH2 was able to eliminate ascites and significantly prolong the survival of mice‐bearing CT26 tumor cells by intraperitoneal injection, without obvious systemic damage to the main organs even though a regional cytokine storm. Hypersecretion of pro‐inflammatory cytokines, mainly IL‐6, and increased infiltration of CD4+ and CD8+ T cells were observed in ascites mice treated by OH2, compared with those treated by 5‐fluorouracil or nonresponders. Furthermore, the initial‐stage blocking of the IL‐6 pathway was able to considerably suppress antitumor immune responses driven by OH2. Surprisingly, we discovered upregulations of the immune checkpoint genes such as Cd274 and Pdcd1 by single‐cell RNA sequencing. Conclusions: OH2 could safely eliminate malignant ascites of colon cancer and convert the cold immune microenvironment by inducing a remarkably regional cytokine storm in ascites, mainly IL‐6, in the early stage of antitumor immune responses beyond directed oncolytic virotherapy. Abstract : OH2 induced a remarkably regional cytokine storm through the direct and exhaustive oncolytic cytotoxicity. The immune checkpoint genes such as Cd274 (encoding PD‐L1) and Pdcd1 (encoding PD1) were up‐regulated of in OH2 group. The initial‐stage blocking to IL‐6 pathway was able to considerably suppress anti‐tumor immune responses driven from OH2. … (more)
- Is Part Of:
- Cancer medicine. Volume 11:Number 22(2022)
- Journal:
- Cancer medicine
- Issue:
- Volume 11:Number 22(2022)
- Issue Display:
- Volume 11, Issue 22 (2022)
- Year:
- 2022
- Volume:
- 11
- Issue:
- 22
- Issue Sort Value:
- 2022-0011-0022-0000
- Page Start:
- 4297
- Page End:
- 4309
- Publication Date:
- 2022-05-05
- Subjects:
- colon cancer -- cytokine -- herpes simplex virus type 2 -- malignant ascites
616.994005 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2045-7634 ↗ - DOI:
- 10.1002/cam4.4772 ↗
- Languages:
- English
- ISSNs:
- 2045-7634
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24373.xml